Nuveen’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
428,165
-372,088
-46% -$1.94M ﹤0.01% 2434
2026
Q1
$3.72M Sell
800,253
-10,026
-1% -$57.4K ﹤0.01% 2003
2025
Q4
$6.3M Sell
810,279
-269,049
-25% -$2.3M ﹤0.01% 1805
2025
Q3
$9M Buy
1,079,328
+612,350
+131% +$5.17M ﹤0.01% 1614
2025
Q2
$3.32M Buy
466,978
+184,321
+65% +$1.37M ﹤0.01% 2076
2025
Q1
$2.47M Sell
282,657
-541,700
-66% -$5.71M ﹤0.01% 2249
2024
Q4
$10.4M Buy
824,357
+326,149
+65% +$3.93M ﹤0.01% 1579
2024
Q3
$5.58M Buy
498,208
+257,375
+107% +$3.01M ﹤0.01% 1940
2024
Q2
$3.09M Sell
240,833
-39,082
-14% -$596K ﹤0.01% 2175
2024
Q1
$4.38M Sell
279,915
-476,563
-63% -$7.51M ﹤0.01% 2055
2023
Q4
$12.5M Buy
756,478
+188,836
+33% +$2.63M ﹤0.01% 1448
2023
Q3
$6.85M Sell
567,642
-1,567
-0.3% -$21.1K ﹤0.01% 1704
2023
Q2
$8.11M Sell
569,209
-152,293
-21% -$2.23M ﹤0.01% 1637
2023
Q1
$11.2M Buy
721,502
+251,105
+53% +$4.06M ﹤0.01% 1412
2022
Q4
$8.2M Buy
470,397
+158,458
+51% +$2.35M ﹤0.01% 1620
2022
Q3
$3.98M Buy
311,939
+142,403
+84% +$1.9M ﹤0.01% 2033
2022
Q2
$1.92M Sell
169,536
-81,239
-32% -$771K ﹤0.01% 2451
2022
Q1
$2.25M Buy
250,775
+31,766
+15% +$431K ﹤0.01% 2447
2021
Q4
$3.13M Buy
219,009
+29,595
+16% +$465K ﹤0.01% 2353
2021
Q3
$2.56M Sell
189,414
-3,163
-2% -$45.2K ﹤0.01% 2553
2021
Q2
$3.02M Sell
192,577
-9,482
-5% -$152K ﹤0.01% 2515
2021
Q1
$3.38M Sell
202,059
-5,594
-3% -$91.4K ﹤0.01% 2358
2020
Q4
$3.19M Buy
207,653
+523
+0.3% +$7.71K ﹤0.01% 2281
2020
Q3
$2.65M Sell
207,130
-5,432
-3% -$70K ﹤0.01% 2240
2020
Q2
$3.04M Buy
212,562
+36,168
+21% +$529K ﹤0.01% 2152
2020
Q1
$2.18M Buy
176,394
+172
+0.1% +$3.3K ﹤0.01% 2146
2019
Q4
$3.8M Sell
176,222
-3,296
-2% -$67.6K ﹤0.01% 2131
2019
Q3
$3.51M Buy
179,518
+444
+0.2% +$8.15K ﹤0.01% 2139
2019
Q2
$3.02M Buy
+179,074
New +$3.06M ﹤0.01% 2243

Other funds holding OSG

Nuveen's OSG Position: Q2 2026 in Review

Nuveen reduced its Octave Specialty Group (OSG) stake by 46% in Q2 2026, selling an estimated $1.94M and leaving 428,165 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2434.

Nuveen first reported a position in OSG in Q2 2019 and has held it in 29 quarters since. The position peaked at $12.5M in Q4 2023. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • Nuveen held 428,165 shares of Octave Specialty Group worth $2.67M as of Q2 2026.
  • Nuveen sold 372,088 Octave Specialty Group shares in Q2 2026, an estimated $1.94M.
  • Octave Specialty Group made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2434 holding.
  • Nuveen first reported a position in Octave Specialty Group in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Octave Specialty Group position peaked at $12.5M in Q4 2023.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.